HIV and AIDS Trial, Recruiting NCT06463886 Sponsor: University of Miami Condition: HIV and AIDS
Back to Hiv Aids

HIV and AIDS Trial, Recruiting

NCT06463886
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who identify as Black
  • People who are living with HIV
  • People who identify as cisgender female (born female and still identify as female)
  • People who are 18 years of age or older
  • People who speak English
  • People whose HIV virus levels in the blood have not been fully controlled (above 200 copies per ml) in the past year, or who have not had their HIV virus levels measured for 6 months or more during the past 12 months
  • People who have a history of trauma or abuse
  • People who are able to understand and complete the consent and study processes

Who may not be able to join:

  • People who are not able to fully understand the consent process or the steps involved in the study
  • People who have significant mental health symptoms that would seriously interfere with taking part, such as untreated active psychosis (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sannisha Dale, PhD, University of Miami

Phone: 3052841991

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
19 August 2024
Est. completion
1 June 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in viral suppression

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov